FDA Warning Letter — Zhejiang Hisoar Pharmaceutical Co. Ltd.
The FDA took a Warning Letter action against Zhejiang Hisoar Pharmaceutical Co. Ltd. on August 11, 2016 (Taizhou, China). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.
Action Details
- Facility
- Zhejiang Hisoar Pharmaceutical Co. Ltd.
- Date
- August 11, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Center
- CDER
- Location
- Taizhou (China)